Evidence map›Paper›PMID 28396764›Full record

ArticleClinical case reports2017

Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantation.

Onyee Chan, Abdur Rehman Jamil, Rebecca Millius, Ramandeep Kaur, Faiz Anwer

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Onyee ChanDepartment of Medicine University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA; Banner University Medical Center - Tucson University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA.ORCID 0000-0003-2872-1961
Abdur Rehman JamilDepartment of Medicine University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA; Banner University Medical Center - Tucson University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA.
Rebecca MilliusBanner University Medical Center - Tucson University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA; Department of Pathology University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA.
Ramandeep KaurBanner University Medical Center - Tucson University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA.
Faiz AnwerDepartment of Medicine University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA; Banner University Medical Center - Tucson University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA; Department of Hematology, Oncology, Blood & Marrow Transplantation University of Arizona 1501 N. Campbell Ave. Tucson Arizona 85724 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mixed phenotype acute leukemia with t(9;22) is a rare disease with poor prognosis, and information on optimal treatment is limited. We describe a case where our patient experienced positive outcome after nonacute myeloid leukemia-type intensive induction therapy followed by postremission therapy with stem cell transplant.

Indexed as

Acute myeloid leukemiaallogeneic stem cell transplantationde novo acute myeloid leukemialeukemia in central nervous systemmixed phenotype acute leukemiaPhiladelphia chromosometyrosine kinase inhibitor

Identifiers

PMID28396764
PMCPMC5378833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.